A study led by Northwestern Medicine investigators found that education and place of birth significantly contribute to racial and ethnic differences in cardiovascular health among U.S. adults.
Browsing: Preventive Medicine
Originally founded in 1972 as a small team of fewer than 10 people, the department has grown to include seven divisions with 285 faculty and staff.
Telmisartan, an angiotensin receptor blocker drug, did not improve walking performance in patients with lower extremity peripheral artery disease, according to a recent clinical trial published in JAMA.
Mortality rates for ischemic heart disease in Asian American subpopulations were found to be more burdensome than previously reported, according to a Northwestern Medicine study published in JAMA Internal Medicine.
Investigators have identified distinct epigenetic pathways in African American and European American patients diagnosed with multiple myeloma, according to a Northwestern Medicine study.
Mary M. McDermott, MD, ’92 GME, the Jeremiah Stamler Professor of Medicine in the Division of General Internal Medicine, has been honored with the American Heart Association’s 2022 Peripheral Vascular Disease Distinguished Achievement Award.
Polygenic risk scores demonstrated minimal clinical benefit in predicting long-term coronary heart disease when added to a traditional risk factor model, according to a Northwestern Medicine study.
A new study provides evidence that blood epigenetic biomarkers contain “snapshots” of past cardiovascular health exposures and behavior at the molecular level.
Proteins gain new interactions that are potentially oncogenic and could drive cancer development and growth, according to a recent study.
Jody Ciolino, PhD, and Masha Kocherginsky, PhD, faculty in the Department of Preventive Medicine Division of Biostatistics, were elected to the Board of Directors for the Society for Clinical Trials (SCT).